Managing novel orally administered anticoagulants in patients undergoing urogynaecological surgery

The use of novel orally administered anticoagulant agents (NOACs) provides new challenges to clinicians in the perioperative care of patients undergoing urogynaecological surgery. We aimed to assess evidence for managing patients taking NOACs before and after urogynaecological surgery. We conducted...

Full description

Saved in:
Bibliographic Details
Published in:International Urogynecology Journal 2016-04, Vol.27 (4), p.529-535
Main Authors: McCarthy, Claire M., O’Sullivan, Orfhlaith E., O’Reilly, Barry A.
Format: Article
Language:English
Subjects:
Administration, Oral
Anticoagulants - administration & dosage
Clinical Opinion
Female
Gynecologic Surgical Procedures
Gynecology
Humans
Medicine
Medicine & Public Health
Perioperative Care
Practice Guidelines as Topic
Risk Assessment
Urologic Surgical Procedures
Urology
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The use of novel orally administered anticoagulant agents (NOACs) provides new challenges to clinicians in the perioperative care of patients undergoing urogynaecological surgery. We aimed to assess evidence for managing patients taking NOACs before and after urogynaecological surgery. We conducted a literature search in CINAHL, MEDLINE, CENTRAL, Cochrane Library and PubMed for original research articles in the English language on this topic. However, despite initially identifying 556 articles, no articles pertained to the use of NOACs in urogynaecological surgery. We subsequently reviewed national and international guidance on managing patients prescribed NOACs and created a concise guideline to aid urogynaecologists in the perioperative care of these patients. Consensus is needed on perioperative optimisation of anticoagulation in urogynaecological patients using NOACs.
ISSN:0937-3462
1433-3023
DOI:10.1007/s00192-015-2931-2